NL-OMON45798撤回不适用
The consequences of mepolizumab-mediated depletion of eosinophils on adaptive and innate immune responses. - MEPO-AIR
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •severe asthma
排除标准
- •anemia, very low white blood cell count, anti-inflammatory and/or immunosuppressive medication other than used to treat asthma
研究者
相似试验
招募中
不适用
Mepolizumab for treatment of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome - A pilot studyDRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndromeInflammatory and Immune System - AllergiesACTRN12621001333808St Vincent's Hospital, Sydney8
撤回
不适用
*Differences in effect of treatment with mepolizumab and benralizumab on resident and inflammatory eosinophils.shortness of breath1000170810006436asthmaNL-OMON49549niversitair Medisch Centrum Utrecht72
招募中
不适用
*Differences in effect of treatment with mepolizumab and benralizumab on resident and inflammatory eosinophilsasthmaNL-OMON52251niversitair Medisch Centrum Utrecht72
进行中（未招募）
1 期
English Study evaluating safety and efficacy of mepolizumab in the treatment of COPD patients with frequent exacerbations.EUCTR2013-004297-98-GBGlaxoSmithKline Research & Development Ltd660
进行中（未招募）
1 期
English Study evaluating safety and efficacy of mepolizumab in the treatment of COPD patients with frequent exacerbations.EUCTR2013-004297-98-ROGlaxoSmithKline Research & Development Ltd675